Literature DB >> 28010993

Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997-2016: a population-based cohort study.

Joanne R Morling1, David A McAllister2, Wael Agur3, Colin M Fischbacher4, Cathryn M A Glazener5, Karen Guerrero6, Leanne Hopkins4, Rachael Wood7.   

Abstract

BACKGROUND: Concerns have been raised about the safety of surgery for stress urinary incontinence and pelvic organ prolapse using transvaginal mesh. We assessed adverse outcomes after first, single mesh procedures and comparable non-mesh procedures.
METHODS: We did a cohort study of women in Scotland aged 20 years or older undergoing a first, single incontinence procedure or prolapse procedure during 1997-98 to 2015-16 identified from a national hospital admission database. Primary outcomes were immediate postoperative complications and subsequent (within 5 years) readmissions for later postoperative complications, further incontinence surgery, or further prolapse surgery. Poisson regression models were used to compare outcomes after procedures carried out with and without mesh.
FINDINGS: Between April 1, 1997, and March 31, 2016, 16 660 women underwent a first, single incontinence procedure, 13 133 (79%) of which used mesh. Compared with non-mesh open surgery (colposuspension), mesh procedures had a lower risk of immediate complications (adjusted relative risk [aRR] 0·44 [95% CI 0·36-0·55]) and subsequent prolapse surgery (adjusted incidence rate ratio [aIRR] 0·30 [0·24-0·39]), and a similar risk of further incontinence surgery (0·90 [0·73-1·11]) and later complications (1·12 [0·98-1·27]); all ratios are for retropubic mesh. During the same time period, 18 986 women underwent a first, single prolapse procedure, 1279 (7%) of which used mesh. Compared with non-mesh repair, mesh repair of anterior compartment prolapse was associated with a similar risk of immediate complications (aRR 0·93 [95% CI 0·49-1·79]); an increased risk of further incontinence (aIRR 3·20 [2·06-4·96]) and prolapse surgery (1·69 [1·29-2·20]); and a substantially increased risk of later complications (3·15 [2·46-4·04]). Compared with non-mesh repair, mesh repair of posterior compartment prolapse was associated with a similarly increased risk of repeat prolapse surgery and later complications. No difference in any outcome was observed between vaginal and, separately, abdominal mesh repair of vaginal vault prolapse compared with vaginal non-mesh repair.
INTERPRETATION: Our results support the use of mesh procedures for incontinence, although further research on longer term outcomes would be beneficial. Mesh procedures for anterior and posterior compartment prolapse cannot be recommended for primary prolapse repair. Both vaginal and abdominal mesh procedures for vaginal vault prolapse repair are associated with similar effectiveness and complication rates to non-mesh vaginal repair. These results therefore do not clearly favour any particular vault repair procedure. FUNDING: None.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 28010993     DOI: 10.1016/S0140-6736(16)32572-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

Review 1.  Canadian Urological Association position statement on the use of transvaginal mesh.

Authors:  Blayne Welk; Kevin V Carlson; Richard J Baverstock; Stephen S Steele; Gregory G Bailly; Duane R Hickling
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

2.  Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.

Authors:  Evangelia Bakali; Eugenie Johnson; Brian S Buckley; Paul Hilton; Ben Walker; Douglas G Tincello
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

3.  Leaking in silence: women with stress urinary incontinence who do not have access to or refuse surgery.

Authors:  Renly Lim; Men Long Liong; Kah Hay Yuen
Journal:  Int Urogynecol J       Date:  2018-01-08       Impact factor: 2.894

4.  Intraluminal mesh migration causing enteroenteric and enterocutaneous fistula: a case and discussion of the 'mesh problem'.

Authors:  Reeya Patel; Thomas H Reid; Sam G Parker; Alistair Windsor
Journal:  BMJ Case Rep       Date:  2018-04-17

5.  Outcome of surgical management for midurethral sling complications: a multicentre retrospective cohort study.

Authors:  Victoria Kershaw; Rachel Nicholson; Paul Ballard; Aethele Khunda; Santhosh Puthuraya; Elaine Gouk
Journal:  Int Urogynecol J       Date:  2019-01-07       Impact factor: 2.894

6.  Association between method of pelvic organ prolapse repair involving the vaginal apex and re-operation: a population-based, retrospective cohort study.

Authors:  You Maria Wu; Jennifer Reid; Queena Chou; Barry MacMillan; Yvonne Leong; Blayne Welk
Journal:  Int Urogynecol J       Date:  2018-10-16       Impact factor: 2.894

7.  Management of complications arising from the use of mesh for stress urinary incontinence-International Urogynecology Association Research and Development Committee opinion.

Authors:  Jonathan Duckett; Barbara Bodner-Adler; Suneetha Rachaneni; Pallavi Latthe
Journal:  Int Urogynecol J       Date:  2019-03-27       Impact factor: 2.894

8.  Transvaginal single-port laparoscopic pelvic reconstruction with Y-shaped mesh: experiences of 93 cases.

Authors:  Junwei Li; Changdong Hu; Xiaojuan Wang; Keqin Hua; Yisong Chen
Journal:  Int Urogynecol J       Date:  2020-07-31       Impact factor: 2.894

9.  Long-term Rate of Mesh Sling Removal Following Midurethral Mesh Sling Insertion Among Women With Stress Urinary Incontinence.

Authors:  Ipek Gurol-Urganci; Rebecca S Geary; Jil B Mamza; Jonathan Duckett; Dina El-Hamamsy; Lucia Dolan; Douglas G Tincello; Jan van der Meulen
Journal:  JAMA       Date:  2018-10-23       Impact factor: 56.272

10.  Outcomes after laparoscopic removal of retropubic midurethral slings for chronic pain.

Authors:  Elizabeth J Goodall; Rufus Cartwright; Emily C Stratta; Simon R Jackson; Natalia Price
Journal:  Int Urogynecol J       Date:  2018-09-18       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.